Three-year clinical outcomes of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: A prospective patient-level pooled analysis of NeoVas trials.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions（2023）
摘要
The extended outcomes of the NeoVas objective performance criterion trial demonstrated a promising 3-year efficacy and safety of the NeoVas BRS in low-risk patients with low complexity in terms of lesions and comorbidities.
更多查看译文
关键词
bioresorbable scaffold,coronary artery disease,objective performance criterion,percutaneous coronary intervention,sirolimus-eluting stents
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要